Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (1)
Filter
Search Result
Results for "

ulodesine

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | Inhibitors_Agonists
Ulodesine
BCX4208
T67822L548486-59-5In house
Ulodesine (BCX4208) is a purine nucleoside phosphorylase (PNP) inhibitor that inhibits PNP with an IC50 value of 2.293 nM L. Ulodesine may be used to study hyperuricaemia.
  • Inquiry Price
6-8weeks
Size
QTY
Ulodesine succinate anhydrous
Ulodesine, DADMe-immucillin H, BCX-4208, BCX4208, BCX 4208
T2029831246200-39-4
Ulodesine (also known as BCX4208) is a purine nucleotide phosphorylase (PNP) inhibitor being developed by Biocryst for the treatment of gout. Intended as a once-daily oral therapy, it functions by impacting the purine metabolic pathway upstream of xanthine oxidase to decrease serum uric acid (sUA) levels. Its half-maximal inhibitory concentration (IC(50)) for PNP is 0.5 nM. Currently, BCX-4208 is in early clinical trials to evaluate its potential benefits in treating psoriasis and gout.
  • Inquiry Price
Size
QTY